Summary
Amgen Inc. (AMGN) filed an 8-K on May 5, 2005, to report an update on its ongoing exchange offer. The company announced a one-day extension of the offer, which allows holders of its outstanding Liquid Yield Option Notes due 2032 to exchange them for new Zero Coupon Convertible Notes due 2032. This extension provides noteholders with additional time to consider the terms of the exchange offer. The primary purpose of this filing is to inform investors and stakeholders about the adjustment in the offer's timeline. Investors holding the Liquid Yield Option Notes should note this extended period for decision-making regarding the conversion into the new convertible notes. Further details of the offer, including the terms and conditions of the new notes, would be available in the referenced press release (Exhibit 99.1).
Key Highlights
- 1Amgen Inc. announced a one-day extension for its exchange offer.
- 2The exchange offer involves swapping outstanding Liquid Yield Option Notes due 2032 for new Zero Coupon Convertible Notes due 2032.
- 3The event date for this announcement was May 3, 2005.
- 4The filing was made on May 4, 2005, with the report dated May 5, 2005.
- 5This 8-K filing includes a press release dated May 4, 2005, as Exhibit 99.1, detailing the extension.
- 6The extension provides additional time for holders of the existing notes to make a decision.
- 7The filing also serves to satisfy reporting obligations related to written communications under Rule 425 of the Securities Act.